These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sézary syndrome in an 11-year-old girl. Meister L; Duarte AM; Davis J; Perez JL; Schachner LA J Am Acad Dermatol; 1993 Jan; 28(1):93-5. PubMed ID: 8425978 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome. Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887 [TBL] [Abstract][Full Text] [Related]
7. New and established treatment options for mycosis fungoides and Sézary syndrome - an update. Dugas-Breit S; Schulze HJ; Hallermann C J Dtsch Dermatol Ges; 2014 Jul; 12(7):561-9. PubMed ID: 24889480 [TBL] [Abstract][Full Text] [Related]
8. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma. McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma. Boehncke WH; König K; Rück A; Kaufmann R; Sterry W Acta Derm Venereol; 1994 May; 74(3):201-5. PubMed ID: 7915462 [TBL] [Abstract][Full Text] [Related]
10. The Sézary syndrome. James MP; Warin AP Clin Exp Dermatol; 1979 Jun; 4(2):255-61. PubMed ID: 498579 [No Abstract] [Full Text] [Related]